Skip to main content

Main menu

  • Home
  • Articles
    • Current issue
    • ERJ Early View
    • Archive
  • About
    • About continuous publication
    • Journal information
    • Editorial Board
    • CME
    • Press office
    • Permissions and reprints
    • Advertising
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
  • For readers
    • Alerts
    • Subjects
    • Podcasts
    • RSS
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Articles
    • Current issue
    • ERJ Early View
    • Archive
  • About
    • About continuous publication
    • Journal information
    • Editorial Board
    • CME
    • Press office
    • Permissions and reprints
    • Advertising
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
  • For readers
    • Alerts
    • Subjects
    • Podcasts
    • RSS
  • Subscriptions

The impact of using different symptom-based exacerbation algorithms in patients with COPD

J.C.A. Trappenburg, A.C. van Deventer, T. Troosters, T.J.M. Verheij, A.J.P. Schrijvers, J-W.J. Lammers, E.M. Monninkhof
European Respiratory Journal 2011; DOI: 10.1183/09031936.00130910
J.C.A. Trappenburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.C. van Deventer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Troosters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T.J.M. Verheij
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.J.P. Schrijvers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-W.J. Lammers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.M. Monninkhof
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Not all exacerbations are captured by reliance on healthcare contacts. Symptom-based exacerbation definitions have shown to provide more adequate measures of exacerbation rates, severity and duration. Still, no consensus is reached on what is the most useful method and algorithm to identify these events. This article provides an overview of the existing symptom-based definitions and tested the hypothesis that differences in exacerbation characteristics depend on the algorithms used.

We systematically reviewed symptom-based methods and algorithms used in the literature and quantified the impact of the four most referenced algorithms on exacerbation-related outcome using an existing COPD cohort (n=137).

We identified 51 studies meeting our criteria using 14 widely varying symptom algorithms to define onset, severity and recovery. The most (71%) frequently referenced algorithm (modified Anthonisen) identified an incidence rate of 1.7 (1.4–2.1) episodes per patient-year, while for requiring only one major or two major symptoms this was 1.9 (1.6–2.3) and 1.5 (0.6–1.0) respectively. Studies were generally lacking methods to enhance validity and accuracy of symptom recording.

This review revealed large inconsistencies in definitions, methods and accuracy to define symptom-based COPD exacerbations. We demonstrated that minor changes in symptom criteria substantially affect incidence rates, clustering type and classification of exacerbations.

  • COPD/COPD exacerbations
  • ERS
Next
Back to top
Vol 51 Issue 4 Table of Contents
European Respiratory Journal: 51 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The impact of using different symptom-based exacerbation algorithms in patients with COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
The impact of using different symptom-based exacerbation algorithms in patients with COPD
J.C.A. Trappenburg, A.C. van Deventer, T. Troosters, T.J.M. Verheij, A.J.P. Schrijvers, J-W.J. Lammers, E.M. Monninkhof
European Respiratory Journal Jan 2011, erj01309-2010; DOI: 10.1183/09031936.00130910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The impact of using different symptom-based exacerbation algorithms in patients with COPD
J.C.A. Trappenburg, A.C. van Deventer, T. Troosters, T.J.M. Verheij, A.J.P. Schrijvers, J-W.J. Lammers, E.M. Monninkhof
European Respiratory Journal Jan 2011, erj01309-2010; DOI: 10.1183/09031936.00130910
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Pulmonary vascular endothelium: an ERS research seminar
  • TASK-1 channels in the lung: cell biology to clinical implications
  • Th17 cytokines as therapeutic targets for COPD
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Collections
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Fax: +44 114 266 5064
Email: info@ersj.org.uk

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2018 by the European Respiratory Society